Skip to content

Vistagen Therapeutics, Inc.

VTGN

CIK 0001411685 · Pharmaceutical Preparations · Nasdaq

  • Excaliber Enterprises, Ltd. (until 2011-06-08)
← back to feed
Revenue (TTM)
$1M
−2.2% YoY FY Jun 2026
Net Income (TTM)
−$67.5M
−35.5% YoY FY Jun 2026
EPS Diluted (TTM)
−$1.92
−9.6% YoY FY Jun 2026
Gross Margin
—
FY Jun 2026
Operating Margin
-7,040.3%
FY Jun 2026
Net Margin
-6,738.5%
FY Jun 2026
Free Cash Flow (TTM)
−$53.77M
FY Jun 2026
Cash
$30.79M
FY Jun 2026
Total Debt
$105K
FY Jun 2026
Shares Outstanding
41.03M sh
FY Jun 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings